Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Brain Neoplasms × durvalumab × Clear all

Phase

Status

Terminated 1 Recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Hepatocellular 26 Carcinoma, Non-Small-Cell Lung 19 Lung Neoplasms 14 Cholangiocarcinoma 13 Biliary Tract Neoplasms 13 Small Cell Lung Carcinoma 11 Triple Negative Breast Neoplasms 7 Breast Neoplasms 6 Liver Neoplasms 5 Urinary Bladder Neoplasms 4 Pancreatic Neoplasms 4 Neoplasms 4 Neoplasm Metastasis 4 Carcinoma 4 Stomach Neoplasms 3 Non-Muscle Invasive Bladder Neoplasms 3 Gallbladder Neoplasms 3 Ovarian Neoplasms 2 Esophageal Neoplasms 2 Endometrial Neoplasms 2 Bile Duct Neoplasms 2 Advanced Biliary Tract Cancer 2 Adenocarcinoma of Lung 2 Adenocarcinoma Of Esophagus 2 Adenocarcinoma 2 Vaccinia 1 Unresectable Hepatocellular Carcinoma 1 SCLC, Limited Stage 1 Renal Pelvis and Ureter Urothelial Carcinoma 1 Recurrence 1

Interventions

Radiosurgery 24 Magnetic Resonance Spectroscopy 20 Temozolomide 12 pembrolizumab 10 Bevacizumab 9 Specimen Handling 8 Radiotherapy 6 Nivolumab 6 Ipilimumab 6 Magnetic Resonance Imaging 5 Cyclophosphamide 5 Capecitabine 5 Radiation 4 Neuropsychological Tests 4 Mental Status and Dementia Tests 4 Carboplatin 4 fludarabine 3 fluciclovine F-18 3 encorafenib 3 abemaciclib 3 Proton Therapy 3 Etoposide 3 Dexamethasone 3 Blood Specimen Collection 3 Adrenal Cortex Hormones 3 trastuzumab deruxtecan 2 osimertinib 2 niraparib 2 fluoromisonidazole 2 binimetinib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04711824 2025-12-23

SOLARA

Hoosier Cancer Research Network

Phase 1/2 Recruiting

Brain Neoplasms, Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡